SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.83-0.7%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (24433)8/12/1998 10:57:00 PM
From: Machaon  Read Replies (3) of 32384
 
Hmmmm!? That means that "we" as shareholders just bought around $220 million in drug development and science, and a revenue producing drug, for about $75 million, providing that ONTAK gets approved.

That's a $145 million discount, otherwise known as a fire sale.

There's another 4 or 5? fusion protein compounds in the pipeline.

Doesn't sound like too bad a deal to me, unless the science of fusing a poisonous substance and a protein doesn't work. But, SRGN at least got it as far as the FDA, so there must be some merit to it.

Good luck, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext